Retraction notices

Tumor Dependence on the EGFR Signaling Pathway Expressed by the p-EGFR:p-AKT Ratio Predicts Erlotinib Sensitivity in Human Non-small Cell Lung Cancer (NSCLC) Cells Expressing Wild-Type EGFR Gene

Type
Retraction
Notice date
8/16/2021 0:00
Journal
Journal of Thoracic Oncology
Publisher
Elsevier
Notice DOI
10.1097/jto.0b013e3181753b24
Original paper DOI
10.1097/jto.0b013e3181753b24

Reasons

Matching venue names

Name match only, not an authoritative journal identifier.